India's Covid-19 trajectory has taken a sharp upward turn since the end of May, sparking fears of a potential new wave of infections. The active Covid-19 cases rose to 6,815 as of June 11—considerably higher than only 257 cases on May 22—according to the Union Ministry of Health dashboard.

Over the last 24 hours alone, the nation logged 324 fresh cases, accompanied by 783 recoveries and three new virus-linked deaths. This increase, while not yet a major outbreak by any means, indicates a change that will be monitored—specifically because states such as Kerala, Gujarat, and Karnataka are registering a steady rise.

Public health agencies have cautioned that although the severity of infections as a whole is still under control because of high inoculation levels and hybrid immunity, susceptible groups, particularly the elderly and those who suffer from co-morbidities, are still under substantial risk of developing complications or dying.

Three further Covid-related deaths were reported on June 10, taking India's death toll in 2025 to 68. These comprised:

A 90-year-old female in Delhi with co-morbidities such as Congestive Heart Failure (CCF), Chronic Kidney Disease (CKD), and respiratory acidosis.

A 79-year-old male in Kerala, who was controlling Type 2 diabetes and other chronic diseases.

A 44-year-old male in Jharkhand, who had severe multiple conditions such as aspirational pneumonia, acute respiratory distress syndrome (ARDS), septic shock, hypertension, and hypothyroidism.

These examples highlight a stern reality: even with advances in medical interventions, Covid-19 is risky—particularly for individuals with compromised immune systems or existing health issues.

Kerala has the highest active caseload currently, with 2,053 active infections and 96 fresh cases in the past 24 hours. Even with its strong healthcare setup and high awareness rate, the state continues to fight against the virus due to its ageing population and lifestyle disease prevalence.

Gujarat is next, with 1,109 active cases, with Surat alone having 166. Karnataka, which logged 136 new cases in 24 hours, is another hotbed, reporting two deaths in the past 24 hours.

Incidentally, Delhi, having reported one death, registered a drop in active cases—691 now. Experts attribute this to timely public health interventions and increasing immunity in cities.

Why Are Hospital Admissions Being Led by High-Risk Patients?

Although the majority of new infections have been asymptomatic or mild, hospitalizations are disproportionately accounted for by high-risk groups, such as the elderly and those with underlying health conditions.

Recent fatalities in Delhi and Jharkhand included patients who were either old or had concurrent chronic diseases. According to medical professionals, these patients have lesser ability to develop an adequate immune response, and therefore they are prone to develop complications such as sepsis, respiratory failure, or multi-organ dysfunction if they contract Covid-19.

To an international audience, India's current Covid-19 data are not mere figures—what they show is a dynamic, living picture of how the pandemic is being addressed in one of the world's most populated countries.

The rebound is a warning for other nations that have reduced Covid-19 monitoring. The combination of declining immunity, viral evolution, and underreporting may easily spur new waves in other parts of the world, particularly as travel expands and public complacency deepens.

India's widespread Covid-19 surveillance system presents early notice of the potential for new variants and geographic trends. A spike here may, in the past, herald a ripple effect worldwide—as was the case with previous waves.

Why Are Individuals with Co-Morbidities Experiencing the Worst Outcomes?

The link between co-morbidities and worse Covid-19 outcomes has been clear from the beginning of the pandemic. Diseases such as diabetes, heart disease, kidney issues, obesity, and weakened immune systems severely limit the body's capacity to resist infection. Here's why:

Impaired Immune Function: Chronic diseases weaken the immune system's capability to detect and fight new infections efficiently.

Elevated Inflammatory Biomarkers: Underlying diseases tend to raise baseline levels of inflammation within the body, which in the event of a Covid-19 infection can spiral out of control into cytokine storms and serious systemic complications.

Delayed Hospitalization or Diagnosis: Most at-risk patients avoid care because of overlapping symptoms or ignorance, resulting in late disease at presentation.

Drug Interactions and Treatment Limits: Many patients with chronic diseases are already on medication regimens that can complicate Covid treatment, limiting options for antiviral therapies or supportive interventions.

The elderly and those with multiple diseases often experience rapid progression from mild symptoms to severe respiratory distress or organ failure. Vigilant monitoring and early intervention are critical in such cases.

Is a New COVID-19 Wave Here?

While India is witnessing a sharp rise in Covid-19 cases—jumping from just 257 active cases on May 22 to nearly 7,000 by June 11—experts are cautious about declaring it a full-blown new wave. The current surge appears localized, with states like Kerala, Gujarat, and Karnataka leading the spike. Most cases remain mild, and hospitalizations are limited to high-risk individuals with co-morbidities. Health officials are tracking for emerging variants closely but have not yet spotted any concerning mutations. Although it is not a new wave, the trend points to calls for increased vigilance, in particular for the elderly and the immunocompromised.

Indian health officials are calling for continued wearing of masks in risk areas, booster doses of vaccination, and early reporting of symptoms—particularly among vulnerable groups.

A few state health departments are stepping up genome sequencing and contact tracing in order to eliminate the possibility of any new sub-variants that could be fuelling this upsurge. There is no official confirmation on a new variant yet, but researchers are keeping a lookout.

The Union Health Ministry is also urging enhanced hospital readiness, reconsidering oxygen and ventilator inventories, and releasing advisories to local governments to stay vigilant.

All India Institute of Medical Sciences (AIIMS) and the Indian Space Research Organisation (ISRO) signed a Memorandum of Understanding (MoU) on Monday to collaborate on advancing research in space medicine.

The MoU was signed between M Srinivas, Director (AIIMS), New Delhi and Dinesh Kumar Singh, Director, Human Space Flight Centre (HSFC), ISRO. The event brought together senior leadership from AIIMS and ISRO, including ISRO Chairman V Narayanan and Secretary, Department of Space, as well as Deans, Heads of Departments, faculty members, and studies from AIIMS New Delhi.

As per the news agency Asian News International (ANI), a press release of the collaboration noted for a cooperative framework for ground-based and space-based research in Space Medicine. The press release also noted that the research will cover areas like human physiology, cardiovascular and autonomic regulation, musculoskeletal health in microgravity, microbiome and immunology, genomics and biomarkers and behavioral health.

“This MoU will give us the escape velocity to venture together into the field of space medicine. Collaborative research between AIIMS and ISRO will benefit patients, the nation, and ultimately humankind. As India moves toward Viksit Bharat by 2047, we hope to emerge as a Vishwaguru in space medicine as well,” said Prof M Srinivas, Director, AIIMS, New Delhi.

Chairman of ISRO Dr V Narayanan and Secretary, Department of Space also highlighted India’s remarkable journey in space programme. He noted how India evolved from the time when rockets and equipment were transported on bicycles and bullock carts to today, where it is going to be leading medical and research institutions like AIIMS to strengthen India’s human spaceflight capabilities.

The programme also featured a presentation on AIIMS New Delhi’s ongoing work in space medicine research, delivered by Prof. KK Deepak, former Head of the Department of Physiology. The event was attended by Heads of Departments and faculty members from across AIIMS New Delhi, along with representatives from the Resident Doctors Association (RDA), the AIIMS Student Association (ASA), and the Society of Young Scientists (SYS).

The collaboration represents an important step toward enhancing India’s capabilities in human spaceflight and biomedical research. It also aligns with the country’s broader scientific ambitions as India moves toward its centenary in 2047 and the vision of Viksit Bharat.

Read: Sunita Williams Retires After 27 Years: Health Challenges She Faced After Spending 600+ Days in Space

What Do We Already Know About Space Medicine?

As per a 2017 study in the British Journal of Anaesthesia, space medicine is fundamental to the human exploration of space. It supports survival, function and performance in this challenging as potentially lethal environment. It is international, intercultural and interdisciplinary, operating at the boundaries of exploration, science, technology and medicine.

Space medicine specialists play a crucial role in safeguarding astronauts and other spaceflight participants. Known as “flight surgeons,” they help develop strategies to protect the health, safety, and performance of space travellers in the extreme conditions of space. Their responsibilities span every stage of a mission — from selection and training to in-flight care, post-mission rehabilitation, and monitoring long-term health effects.

With inputs from ANI

Sick days are again piling up with a respiratory disease, not COVID-19 or the flu. This disease is most likely the one Americans have not heard of. This is HMPV or human metapneumovirus. Doctors have asked people to stay vigilant as seasonal flu virus could lead to pneumonia and bronchitis, and it is spreading in California wastewater and around the country. However, as per public health officials, there is nothing to get worried at this point.

Also Read: Is There A Link Between Your Kidney Health And Other Chronic Diseases? Study Says Yes

As per the public database WasterwaterScan Dashboard, high levels of HMPV were detected across Northern California cities. The highest levels were reported in Redwood City, whereas elevated levels were found in San Francisco Bay Area and Napa's Wine Country. What's more dangerous is that this virus is without a vaccine.

The good news is that in other parts of country HMPV remains lower. However, the Centers for Disease Control and Prevention (CDC) noted that data from October 2025 shows the cases are trending up, especially during winter and spring.

Dr. Matthew Binnicker, director of the Clinical Virology Laboratory at Mayo Clinic, as reported by The Independent said, "In the late winter, early spring, it can account for five percent to 10 percent of all the respiratory infections that we diagnose in the United States. So it's definitely out there." Experts explain that other viruses like HMPV or influenza get a chance when COVID is quieter.

Read: HMPV Virus Cases Surging In California, New Jersey: Is It Dangerous?

Virus Without A Vaccine: What Is HMPV?

HMPV was first discovered in 2001 and is part of the Pneumoviridae family along with the Respiratory syncytial virus (RSV).

HMPV most likely spreads from an infected person to others through:

• the air by coughing and sneezing
• close personal contact, such as touching or shaking hands
• touching objects or surfaces that have the viruses on them, then touching the mouth, nose, or eyes

In the US, HMPV circulates in predictable patterns each year, typically beginning in winter and lasting through spring.

The usually self-limiting and mild symptoms typically last 4 to 5 days. These include:

• cough
• fever
• nasal congestion
• shortness of breath

People at risk include:

• elderly people
• children
• people with comorbidities

"The HMPV is not deadly, and there is no evidence of mortality or a severe transmission rate," former Indian Council of Medical Research (ICMR) scientist, Dr. Raman Gangakhedkar, told IANS, during the virus's outbreak in India in 2025.

“The virus may cause pneumonitis-like illness, but the mortality rates are almost unknown so far. HMPV has a global prevalence of about 4 per cent,” he added.

While no vaccine or treatment can prevent HMPV infection, to avoid the infection, individuals must:

Practice good hygiene and cover your mouth and nose with a tissue when coughing or sneezing, or use your elbow, not your hands, for it. And wash your hands properly, especially in healthcare settings.

Why Are People Hearing About The Virus Without Vaccine Now?

The reason people have not heard about it before is because its symptoms are nearly indistinguishable from other respiratory infections, so often it could go undiagnosed. Furthermore, earlier the COVID cases and influenza cases sparked up, which deviated the attention from HMPV. Now, with the season gone, and increased awareness around respiratory illnesses, greater attention to viruses like HMPV is also paid.

One in seven Indians, or over 14 percent of the population, suffers from some form of mental health disorder. Amid an increasing treatment gap -- up to 90 percent -- seen in several states, especially in North India, the government today reiterated the plan of launching a second National Institute of Mental Health and Neurosciences (NIMHANS) in the northern states.

NIMHANS-2 was first announced by Finance Minister Nirmala Sitharaman during the Union Budget 2026-27, to deliver specialized care for mental health and neurological disorders in north India.

Health experts and policymakers, as part of the government-led Post-Budget Webinar series, highlighted the growing burden of mental and neurological disorders in India and also stressed the urgent need to strengthen institutional capacity to meet emerging healthcare demands.

"One in seven Indians is affected by mental health disorders, while several states continue to face a treatment gap ranging from 70 to 90 percent," the experts said.

Noting that Non-Communicable Diseases (NCDs) account for over 60 percent of deaths in the country, they added that "neurological and mental health conditions are among the leading contributors to disability-adjusted life years (DALYs)," among the citizens.

Need For Tertiary Neuro-psychiatric Care

To address these, the experts called for ramping up tertiary mental health institutions and expanding specialized services.

The session, moderated by Vijay Nehra, Joint Secretary, Ministry of Health and Family Welfare, highlighted that North India currently lacks adequate tertiary neuro-psychiatric care facilities. These include areas such as:

• advanced neuroimaging,
• neurocritical care,
• specialized neurological services

Further, making a virtual address at the Post-Budget Webinar, Union Health Minister JP Nadda also highlighted the government’s focus on strengthening mental healthcare services in the country.

"NIMHANS-2 will be established in North India to expand advanced clinical care, training, and research," Nadda said.

"In addition, the Central Institute of Psychiatry, Ranchi, and the Lokopriya Gopinath Bordoloi Regional Institute of Mental Health, Tezpur, will be upgraded as regional apex institutions to strengthen mental healthcare services in the eastern and north-eastern regions," he added.

Meanwhile, the experts also stressed the need to improve services in underserved and geographically remote regions, including the northeastern states, through better infrastructure, capacity building, and targeted deployment of trained mental health professionals.

They also discussed strategies for expanding advanced neuro-psychiatric care and reinforcing India’s overall mental healthcare ecosystem. They proposed:

• Adopting a hub-and-spoke model supported by digital health platforms

This would allow tertiary institutions and centers of excellence to provide technical guidance, specialist consultations, and clinical support to district hospitals and community-level health facilities.

"Such a model would strengthen referral pathways and ensure that specialized mental health services are accessible to people even in remote and rural areas," the experts said.

• Integrating services under Tele-MANAS

Both existing and upcoming campuses of NIMHANS must be integrated , as this will enable a robust nationwide tele-mental health network that ensures

• timely counselling,
• psychological support,
• specialist consultations

• Digital follow-up systems

The experts called for the seamless integration of healthcare facilities, aligned with the vision of the Ayushman Bharat Digital Mission and the ABHA ID ecosystem. This, they said, will

• enable continuity of care,
• Improve monitoring of patients,
• Lead to better clinical outcomes

• A national Brain-Mind Cloud Network

The Network proposed under the National Health Mission would connect premier institutions such as All India Institute of Medical Sciences (AIIMS), state medical colleges, and primary healthcare centers through a digitally integrated platform.

It could also facilitate

• unified mental health records,
• AI-based screening tools,
• data-driven clinical decision support systems,
• tele-neuro-psychiatric hubs at regional centers.